State-of-the-Art Review : Prevention of Venous Thromboembolism in Major Orthopedic Surgery

Venous thromboembolism continues to be a major source of morbidity and mortality in both elective and traumatic orthopedic surgery. Prevention of this complication has received much attention in the orthope dic literature in recent years. We reviewed the relative efficacy and safety of various agents in the prophylaxis of venous thromboembolism arising after major orthopedic surgery. In patients undergoing total hip replacement, low-molecular-weight heparin in fixed doses, adjusted doses of warfarin, and unfractionated heparin in adjusted doses are the most effective prophylactic agents and are highly recommended for routine use. Low-molecular- weight heparin or warfarin should be used in patients with hip fractures. Low-molecular-weight heparin, warfarin, or intermittent pneumatic compression should be used in patients undergoing major knee surgery. A number of questions still remain unanswered. In particular, further studies are needed to establish the optimal duration of prophylaxis.

[1]  M. Verstraete,et al.  Community mental health teams in London are being increasingly stretched , 1997, BMJ.

[2]  J. Hirsh,et al.  Starting prophylaxis for venous thromboembolism postoperatively. , 1995, Archives of internal medicine.

[3]  J. Heit,et al.  Prevention of venous thromboembolism. , 1995, Chest.

[4]  J. Hirsh,et al.  Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery , 1995, Annals of Internal Medicine.

[5]  G. Bannister,et al.  Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. , 1995, The Journal of bone and joint surgery. British volume.

[6]  J. Szalai,et al.  A prospective study of venous thromboembolism after major trauma. , 1994, The New England journal of medicine.

[7]  V. Kakkar,et al.  A Dose Ranging Study to Evaluate Dermatan Sulphate in Preventing Deep Vein Thrombosis following Total Hip Arthroplasty , 1994, Thrombosis and Haemostasis.

[8]  G. Raskob,et al.  A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis Against Deep-Vein Thrombosis After Hip or Knee Implantation , 1994 .

[9]  R. Dittus,et al.  Patient outcomes following tricompartmental total knee replacement. A meta-analysis. , 1994, JAMA.

[10]  R Goeree,et al.  Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[11]  Radcliffe Infirmary,et al.  Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients , 1994, BMJ.

[12]  J. Hirsh,et al.  Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. , 1994, Archives of internal medicine.

[13]  J. Heit,et al.  RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group. , 1994, The Journal of bone and joint surgery. American volume.

[14]  B. O'brien,et al.  Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty , 1993, Annals of Internal Medicine.

[15]  P. Murtaugh,et al.  Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. , 1993, Archives of internal medicine.

[16]  L. Jørgensen,et al.  Prophylaxis of postoperative thromboembolism with low molecular weight heparins , 1993, The British journal of surgery.

[17]  A. T. Berman,et al.  Thromboembolism coincident with tourniquet deflation during total knee arthroplasty , 1993, The Lancet.

[18]  C. Elliott,et al.  Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. The RD Heparin Arthroplasty Group. , 1992, Annals of internal medicine.

[19]  J. Boissel,et al.  Low molecular weight heparin in prevention of perioperative thrombosis. , 1992, BMJ.

[20]  P. Leyvraz,et al.  Thromboembolic prophylaxis in total hip replacement: A comparison between the low molecular weight heparinoid Lomoparan and heparindihydroergotamine , 1992, The British journal of surgery.

[21]  J. Vandenbroucke,et al.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis , 1992, The Lancet.

[22]  A. Nicolaides,et al.  Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. , 1992, International angiology : a journal of the International Union of Angiology.

[23]  C. Francis,et al.  Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. , 1992, JAMA.

[24]  W. Geerts,et al.  Prevention of Deep Vein Thrombosis after Major Knee Surgery - A Randomized, Double-Blind Trial Comparing a Low Molecular Weight Heparin Fragment (Enoxaparin) to Placebo , 1992, Thrombosis and Haemostasis.

[25]  E. Stauffer,et al.  Color-flow duplex scanning for the surveillance and diagnosis of acute deep venous thrombosis. , 1992, Journal of vascular surgery.

[26]  K.,et al.  Prevention of Deep Vein Thrombosis following Total Hip Replacement by Low Molecular Weight Heparinoid , 1992, Thrombosis and Haemostasis.

[27]  P. Brill-Edwards,et al.  Venous thrombosis in patients who have undergone major hip or knee surgery: detection with compression US and impedance plethysmography. , 1991, Radiology.

[28]  J. Parker-Williams,et al.  Major orthopaedic surgery on the leg and thromboembolism. , 1991, BMJ.

[29]  H. Büller,et al.  Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. , 1991, BMJ.

[30]  R. Mollan,et al.  Orthopaedic surgeons and thromboprophylaxis. , 1991, BMJ.

[31]  S. Soimakallio,et al.  Thromboprophylaxis in patients with hip fractures: a prospective, randomized, comparative study between Org 10172 and dextran 70. , 1991, Surgery.

[32]  J. T. ten Cate,et al.  Mechanical prophylaxis of deep vein thrombosis. , 1991, Seminars in thrombosis and hemostasis.

[33]  S. Reis,et al.  Program for the prevention of venous thromboembolism in high-risk orthopaedic patients. , 1991, The Journal of arthroplasty.

[34]  M. Prins,et al.  A Comparison of General Anesthesia and Regional Anesthesia as a Risk Factor for Deep Vein Thrombosis Following Hip Surgery: A Critical Review , 1990, Thrombosis and Haemostasis.

[35]  G. Raskob,et al.  Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. , 1990, JAMA.

[36]  J. Hirsh,et al.  A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. , 1989, Archives of internal medicine.

[37]  J. Hirsh,et al.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. , 1986, The New England journal of medicine.

[38]  R. Pierron.  Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 grams of aspirin daily. , 1985, The Journal of bone and joint surgery. American volume.

[39]  W. Harris,et al.  Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily. , 1985, The Journal of bone and joint surgery. American volume.

[40]  B. Ghelman,et al.  Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. , 1984, The Journal of bone and joint surgery. American volume.

[41]  R. Sautter,et al.  Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement. , 1983, JAMA.

[42]  P. Leyvraz,et al.  Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. , 1983, The New England journal of medicine.

[43]  C. Francis,et al.  Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. , 1983, JAMA.

[44]  J. Galante,et al.  Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. , 1980, British medical journal.

[45]  J. Hirsh,et al.  Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. , 1979, Thrombosis Research.

[46]  M. Stringer,et al.  Prophylaxis of venous thromboembolism , 1990, Proceedings of the Royal Society of Medicine.